84 related articles for article (PubMed ID: 17416521)
1. Discovery and structure-activity relationship studies of indole derivatives as liver X receptor (LXR) agonists.
Bakir F; Kher S; Pannala M; Wilson N; Nguyen T; Sircar I; Takedomi K; Fukushima C; Zapf J; Xu K; Zhang SH; Liu J; Morera L; Schneider L; Sakurai N; Jack R; Cheng JF
Bioorg Med Chem Lett; 2007 Jun; 17(12):3473-9. PubMed ID: 17416521
[TBL] [Abstract][Full Text] [Related]
2. 2-Aryl-N-acyl indole derivatives as liver X receptor (LXR) agonists.
Kher S; Lake K; Sircar I; Pannala M; Bakir F; Zapf J; Xu K; Zhang SH; Liu J; Morera L; Sakurai N; Jack R; Cheng JF
Bioorg Med Chem Lett; 2007 Aug; 17(16):4442-6. PubMed ID: 17587573
[TBL] [Abstract][Full Text] [Related]
3. Discovery and SAR of cinnolines/quinolines as liver X receptor (LXR) agonists with binding selectivity for LXRbeta.
Hu B; Unwalla R; Collini M; Quinet E; Feingold I; Goos-Nilsson A; Wihelmsson A; Nambi P; Wrobel J
Bioorg Med Chem; 2009 May; 17(10):3519-27. PubMed ID: 19394832
[TBL] [Abstract][Full Text] [Related]
4. The RXR agonists PA024 and HX630 have different abilities to activate LXR/RXR and to induce ABCA1 expression in macrophage cell lines.
Nishimaki-Mogami T; Tamehiro N; Sato Y; Okuhira K; Sai K; Kagechika H; Shudo K; Abe-Dohmae S; Yokoyama S; Ohno Y; Inoue K; Sawada J
Biochem Pharmacol; 2008 Oct; 76(8):1006-13. PubMed ID: 18761326
[TBL] [Abstract][Full Text] [Related]
5. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.
DiBlasio-Smith EA; Arai M; Quinet EM; Evans MJ; Kornaga T; Basso MD; Chen L; Feingold I; Halpern AR; Liu QY; Nambi P; Savio D; Wang S; Mounts WM; Isler JA; Slager AM; Burczynski ME; Dorner AJ; LaVallie ER
J Transl Med; 2008 Oct; 6():59. PubMed ID: 18925943
[TBL] [Abstract][Full Text] [Related]
6. Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype.
Lund EG; Peterson LB; Adams AD; Lam MH; Burton CA; Chin J; Guo Q; Huang S; Latham M; Lopez JC; Menke JG; Milot DP; Mitnaul LJ; Rex-Rabe SE; Rosa RL; Tian JY; Wright SD; Sparrow CP
Biochem Pharmacol; 2006 Feb; 71(4):453-63. PubMed ID: 16325781
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin inhibits ABCA1 expression and cholesterol efflux in THP-1 macrophages by an LXR-dependent pathway.
Qiu G; Hill JS
J Cardiovasc Pharmacol; 2008 Apr; 51(4):388-95. PubMed ID: 18427282
[TBL] [Abstract][Full Text] [Related]
8. Discovery of substituted maleimides as liver X receptor agonists and determination of a ligand-bound crystal structure.
Jaye MC; Krawiec JA; Campobasso N; Smallwood A; Qiu C; Lu Q; Kerrigan JJ; De Los Frailes Alvaro M; Laffitte B; Liu WS; Marino JP; Meyer CR; Nichols JA; Parks DJ; Perez P; Sarov-Blat L; Seepersaud SD; Steplewski KM; Thompson SK; Wang P; Watson MA; Webb CL; Haigh D; Caravella JA; Macphee CH; Willson TM; Collins JL
J Med Chem; 2005 Aug; 48(17):5419-22. PubMed ID: 16107141
[TBL] [Abstract][Full Text] [Related]
9. Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia.
Kratzer A; Buchebner M; Pfeifer T; Becker TM; Uray G; Miyazaki M; Miyazaki-Anzai S; Ebner B; Chandak PG; Kadam RS; Calayir E; Rathke N; Ahammer H; Radovic B; Trauner M; Hoefler G; Kompella UB; Fauler G; Levi M; Levak-Frank S; Kostner GM; Kratky D
J Lipid Res; 2009 Feb; 50(2):312-26. PubMed ID: 18812595
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and SAR of potent LXR agonists containing an indole pharmacophore.
Washburn DG; Hoang TH; Campobasso N; Smallwood A; Parks DJ; Webb CL; Frank KA; Nord M; Duraiswami C; Evans C; Jaye M; Thompson SK
Bioorg Med Chem Lett; 2009 Feb; 19(4):1097-100. PubMed ID: 19167885
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of liver x receptor/retinoid X receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro.
Padovani AM; Molina MF; Mann KK
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1228-36. PubMed ID: 20339114
[TBL] [Abstract][Full Text] [Related]
12. Biarylether amide quinolines as liver X receptor agonists.
Bernotas RC; Singhaus RR; Kaufman DH; Ullrich J; Fletcher H; Quinet E; Nambi P; Unwalla R; Wilhelmsson A; Goos-Nilsson A; Farnegardh M; Wrobel J
Bioorg Med Chem; 2009 Feb; 17(4):1663-70. PubMed ID: 19162487
[TBL] [Abstract][Full Text] [Related]
13. Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice.
Peng D; Hiipakka RA; Dai Q; Guo J; Reardon CA; Getz GS; Liao S
J Pharmacol Exp Ther; 2008 Nov; 327(2):332-42. PubMed ID: 18723776
[TBL] [Abstract][Full Text] [Related]
14. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
[TBL] [Abstract][Full Text] [Related]
15. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR.
Wong J; Quinn CM; Brown AJ
Biochem J; 2006 Dec; 400(3):485-91. PubMed ID: 16901265
[TBL] [Abstract][Full Text] [Related]
16. Statins inhibit synthesis of an oxysterol ligand for the liver x receptor in human macrophages with consequences for cholesterol flux.
Wong J; Quinn CM; Brown AJ
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2365-71. PubMed ID: 15514210
[TBL] [Abstract][Full Text] [Related]
17. Liver X receptor agonists with selectivity for LXRbeta; N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides.
Swahn BM; Macsari I; Viklund J; Ohberg L; Sjödin J; Neelissen J; Lindquist J
Bioorg Med Chem Lett; 2009 Apr; 19(7):2009-12. PubMed ID: 19264481
[TBL] [Abstract][Full Text] [Related]
18. AMP-activated protein kinase suppresses LXR-dependent sterol regulatory element-binding protein-1c transcription in rat hepatoma McA-RH7777 cells.
Yang J; Craddock L; Hong S; Liu ZM
J Cell Biochem; 2009 Feb; 106(3):414-26. PubMed ID: 19125418
[TBL] [Abstract][Full Text] [Related]
19. Ligation of RAGE with ligand S100B attenuates ABCA1 expression in monocytes.
Kumar P; Raghavan S; Shanmugam G; Shanmugam N
Metabolism; 2013 Aug; 62(8):1149-58. PubMed ID: 23523156
[TBL] [Abstract][Full Text] [Related]
20. Liver X receptor stimulates cholesterol efflux and inhibits expression of proinflammatory mediators in human airway smooth muscle cells.
Delvecchio CJ; Bilan P; Radford K; Stephen J; Trigatti BL; Cox G; Parameswaran K; Capone JP
Mol Endocrinol; 2007 Jun; 21(6):1324-34. PubMed ID: 17405904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
